NCT06579053View on ClinicalTrials.gov

Bioequivalence Study of Spironolactone Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

March 22, 2023

Primary Completion Date

May 5, 2023

Study Completion Date

August 23, 2023

Conditions
Bioequivalence Study
Interventions
DRUG

Spironolactone Tablets (Test)

Take one test tablet each period

DRUG

Spironolactone Tablets (Reference)

Take one reference tablet each period

Trial Locations (1)

200031

Shanghai Xuhui Central Hospital, Shanghai

All Listed Sponsors
lead

SPH Sine Pharmaceutical Laboratories Co., Ltd.

INDUSTRY